CBRS has reached a new lending extreme. Every share in the borrow pool is now lent out — availability has dropped to 0%, the tightest reading since listing. Simultaneously, short interest jumped 24% in a single week to 11.4 million shares, and cost to borrow climbed 70% to just under 2%.
The convergence is clean. All three lending-market indicators moved in the same direction this week.
Short interest hit 11.4 million shares on June 22. That is up from 9.2 million on June 12 and roughly six times the 1.9 million level that held through most of May. The build has been relentless — every session this week added to the position.
Availability reached 0% for the first time in the stock's listed history. As recently as May 27, availability stood at 129%. That collapse happened in under four weeks. With nothing left to lend, new short positions simply cannot be opened regardless of demand.
Cost to borrow rose to 1.99%, up 70% on the week. That rate remains modest relative to heavily contested names, but the direction matters. The lending pool is fully deployed, and the price of existing borrows is now rising.
What makes the CBRS setup unusual is what's happening on the other side.
Six analysts initiated coverage in early June. All six rated the stock a Buy or Outperform. Price targets range from $250 (Morgan Stanley) to $340 (Citigroup), against a current price of $224. The consensus points to roughly 30% upside from here.
The put/call ratio sits at 0.62 — below its 20-day mean of 0.70. Options traders are leaning toward calls. That is a different posture from the bears building short positions in the lending market.
The ORTEX short score has crept up to 67.7 from 55.9 on June 8. That jump coincided with the first wave of analyst initiations — suggesting the short build and the analyst enthusiasm arrived at the same time and are now running in parallel.
Analysts are not ignoring the risks. The bear case for Cerebras is concentrated: the company derives the bulk of its 2026–2028 revenue from a single customer, OpenAI. Early-stage profitability and ambitious long-term targets add further uncertainty. In an AI compute market with well-resourced incumbents, the margin for error is limited.
That customer concentration risk is likely what short sellers are pricing. The analyst community is constructive on the technology. Short sellers appear focused on the business model.
What to watch: Whether cost to borrow accelerates further from 2% as existing borrowers retain their positions — or whether the zero-availability ceiling triggers any covering into the next news cycle. Next earnings are flagged for August 28.
See the live data behind this article on ORTEX.
Open CBRS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
